At a Glance
| BPC-157 | Substance P | |
|---|---|---|
| Class | Peptide | Neuropeptide, Pain mediator, Stress mediator |
| Routes | Subcutaneous InjectionOral | |
| Effects | 6 documented | 7 documented |
BPC-157, a Peptide, and Substance P, a Neuropeptide, Pain mediator, Stress mediator, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. BPC-157 is classified as a Peptide while Substance P is a Neuropeptide, Pain mediator, Stress mediator, meaning they approach altered states through different pharmacological mechanisms. They share 3 documented effects in common, with 3 effects unique to BPC-157 and 4 unique to Substance P. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| BPC-157 | Substance P | |
|---|---|---|
| Class | Peptide | Neuropeptide, Pain mediator, Stress mediator |
| Routes | Subcutaneous InjectionOral | |
| Effects | 6 documented | 7 documented |
| Level | Dose |
|---|
| Threshold | 50 mcg |
| Light | 100–200 mcg |
| Common | 250–500 mcg |
| Strong | 500–750 mcg |
| Heavy | 1000 mcg |
| Level | Dose |
|---|---|
| Threshold | 100 mcg |
| Light | 200–500 mcg |
| Common | 500–1000 mcg |
| Strong | 1000–1500 mcg |
| Heavy | 2000 mcg |
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.